Complementary Options for Symptom Management In Cancer (COSMIC): Assessing Benefits and Harms of Cannabis and Cannabinoid Use Among a Cohort of Cancer Patients Treated in Community Oncology Clinics
- Sponsor:
- Wake Forest University
- Sponsor Study ID:
- WF2304-A172401
- CTO #:
- 104209
- NCT Number:
- NCT06418204
- Phase:
- N/A
- Protocol Type:
- Other
- Age Group:
- Adults
- Disease Sites:
- Breast; Colon; Melanoma, Skin; Non-Hodgkin's Lymphoma; Rectum
- Study Objectives:
- To examine the association between cannabis and/ or cannabinoid use and cancer related symptoms associated monthly for one year in adults newly diagnosed with breast, colorectal, melanoma, non-hodgkin lymphoma, or non-small cell lung cancer who are planning or recently started to receive one or more systemic cancer directed therapies with chemotherapy and/or immune check point inhibitors targeting PD-1, PDL1 or CTLA-4.
- eConsent:
- Not available
- Study Documents:
-
Open Study Documents
(MUSC NetID required for document access)
For more information about this trial please contact the study team:
-
Beaufort Memorial Hospital - SC
- Affiliate Principal Investigator, Turner, Eric, at james.turner@bmhsc.org .
- Study Coordinator, Conran, Crystal, at crystal.conran@bmhsc.org .
-
Medical University of South Carolina
- Principal Investigator, McClure, Erin, at mccluree@musc.edu , or please call +1 843-792-7192.
- Study Coordinator, Wagner, Marissa, at wagnemar@musc.edu .
-
Tidelands Health
- Affiliate Principal Investigator, Milling, Lee, at leemilling@gmail.com .
- Study Coordinator, Roe, Barbara, at broe@tidelandshealth.org .
- Study Coordinator, DeNunzio, Cara, at cdenunzio@tidelandshealth.org .
Trial opened at the following institutions:
Beaufort Memorial Hospital - SC, Tidelands Health, Medical University of South Carolina